Retraction

Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90

Citations (31)

31
Total Citations
4
Post-Retraction
(12.9%)
22
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
0 Within 1 year
3 After 2+ years
1537 Days since retraction (latest)
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing AMPK Reverses the Mesenchymal Phenotype of Cancer ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Potentiation of Paclitaxel Activity by the HSP90 I...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Apr 2021
1537 days after retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Dec 2020
1416 days after retraction
Paper citing AMPK Reverses the Mesenchymal Phenotype of Cancer ...
Unknown Authors
Unknown Journal
Published: Jul 2019
897 days after retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Aug 2018
588 days after retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Jan 2017
Same day as retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: May 2016
248 days before retraction
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer
Abena S. Agyeman, Wesley J. Jun, David A. Proia et al. (7 authors)
Hormones and Cancer Open Access
Published: Feb 2016
25 citations
342 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Jun 2015
594 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Sep 2014
867 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Jun 2014
956 days before retraction
Paper citing Potentiation of Paclitaxel Activity by the HSP90 I...
Unknown Authors
Unknown Journal
Published: Mar 2014
1051 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Feb 2014
1060 days before retraction
Paper citing Potentiation of Paclitaxel Activity by the HSP90 I...
Unknown Authors
Unknown Journal
Published: Jan 2014
1096 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Dec 2013
1137 days before retraction
Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer
Lisha Xiang, Daniele M. Gilkes, Pallavi Chaturvedi et al. (8 authors)
Journal of Molecular Medicine Open Access
Published: Nov 2013
108 citations
1153 days before retraction
Paper citing A novel class of specific Hsp90 small molecule inh...
Unknown Authors
Unknown Journal
Published: Oct 2013
1202 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Oct 2013
1202 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Aug 2013
1244 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Aug 2013
1263 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: May 2013
1338 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Apr 2013
1356 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Apr 2013
1382 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Sep 2012
1586 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Aug 2012
1628 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: May 2012
1720 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Apr 2012
1750 days before retraction
Paper citing Effective Targeting of Triple-Negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Apr 2012
1750 days before retraction
Quick Stats
Total Citations: 31
Years Since Retraction: 8.9 years
Open Access: Yes
Last Checked: Never
Related Papers
KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Prom…
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 79 citations
Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcin…
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 96 citations
Tumor Escape from Endogenous, Extracellular Matrix-Associat…
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 164 citations
CD44 Expression Denotes a Subpopulation of Gastric Cancer C…
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research • 181 citations